BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33275488)

  • 1. Addressing the Dilemma of Contralateral Prophylactic Mastectomy With Behavioral Science.
    Sacks GD; Morrow M
    J Clin Oncol; 2021 Feb; 39(4):269-272. PubMed ID: 33275488
    [No Abstract]   [Full Text] [Related]  

  • 2. An Evaluation of the Choice for Contralateral Prophylactic Mastectomy and Patient Concerns About Recurrence in a Reconstructed Cohort.
    Sando IC; Billig JI; Ambani SW; Kraft CT; Kidwell KM; Zhong L; Chung KC; Momoh AO
    Ann Plast Surg; 2018 Apr; 80(4):333-338. PubMed ID: 29166308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: What Drives Contralateral Prophylactic Mastectomy?
    Schellenberg AE; Scheer AS
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):821-822. PubMed ID: 31667725
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of anticipated financial burden on patient decision to undergo contralateral prophylactic mastectomy.
    Huang J; Chagpar A
    Surgery; 2018 Oct; 164(4):856-865. PubMed ID: 30093279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral Prophylactic Mastectomy and Immediate Breast Reconstruction in High-Risk Women: The Importance of Health-Related Quality of Life in Decision Making.
    Lemaine V
    Ann Surg Oncol; 2017 Sep; 24(9):2434-2435. PubMed ID: 28600730
    [No Abstract]   [Full Text] [Related]  

  • 6. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
    Greener JR; Bass SB; Lepore SJ
    J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Emotion in Cancer Surgery Decisions: Applying Concepts From Decision Psychology.
    Lee CN; Merrill AL; Peters E
    Ann Surg; 2021 Jun; 273(6):e265-e267. PubMed ID: 33156060
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
    Huang J; Chagpar A
    Am J Surg; 2020 Jun; 219(6):1036-1038. PubMed ID: 31570198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
    Montagna G; Morrow M
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):159-166. PubMed ID: 32077338
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
    Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
    Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Rendle KA; Halley MC; May SG; Frosch DL
    Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
    Terkelsen T; Rønning H; Skytte AB
    Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
    Braude L; Kirsten L; Gilchrist J; Juraskova I
    Psychooncology; 2018 Oct; 27(10):2349-2356. PubMed ID: 29966172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Venetis MK; MacGeorge EL; Baptiste DF; Mouton A; Friley LB; Pastor R; Hatten K; Lagoo J; Bowling MW; Clare SE
    Am J Clin Oncol; 2018 Jun; 41(6):519-525. PubMed ID: 27465657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
    Franceschini G; Di Leone A; Masetti R
    Patient Educ Couns; 2019 Aug; 102(8):1573-1574. PubMed ID: 30905494
    [No Abstract]   [Full Text] [Related]  

  • 20. Contralateral prophylactic mastectomy.
    Benson JR; Winters ZE
    Br J Surg; 2016 Sep; 103(10):1249-50. PubMed ID: 27465285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.